HMGCR and Hypercholesterolemia: Although several classes of pharmaceutical agents have been approved for use as cholesterol-lowering agents, HMG-CoA reductase inhibitors or ‘statins’ are the most efficacious and are currently regarded as standard, first-line therapy worldwide for the treatment of hypercholesterolaemia.